Global Immuno-Oncology Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 92
Published Date: 02 Jan 2024
Category: Medical Care
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Immuno-Oncology market size was valued at USD 44910 million in 2023 and is forecast to a readjusted size of USD 114190 million by 2030 with a CAGR of 14.3% during review period.
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
The Global Info Research report includes an overview of the development of the Immuno-Oncology industry chain, the market status of Hospitals (Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy), Drugstores (Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immuno-Oncology.
Regionally, the report analyzes the Immuno-Oncology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immuno-Oncology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immuno-Oncology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immuno-Oncology industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immuno-Oncology market.
Regional Analysis: The report involves examining the Immuno-Oncology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immuno-Oncology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immuno-Oncology:
Company Analysis: Report covers individual Immuno-Oncology players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immuno-Oncology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Drugstores).
Technology Analysis: Report covers specific technologies relevant to Immuno-Oncology. It assesses the current state, advancements, and potential future developments in Immuno-Oncology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immuno-Oncology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immuno-Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Market segment by Application
Hospitals
Drugstores
Others
Market segment by players, this report covers
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology, with revenue, gross margin and global market share of Immuno-Oncology from 2019 to 2024.
Chapter 3, the Immuno-Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-Oncology market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology.
Chapter 13, to describe Immuno-Oncology research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Immuno-Oncology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immuno-Oncology by Type
1.3.1 Overview: Global Immuno-Oncology Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Immuno-Oncology Consumption Value Market Share by Type in 2023
1.3.3 Immune Checkpoint Inhibitors
1.3.4 Cytokine-Based Immunotherapy
1.3.5 Cancer Vaccines
1.3.6 CAR-T Cell Therapy
1.3.7 Others
1.4 Global Immuno-Oncology Market by Application
1.4.1 Overview: Global Immuno-Oncology Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Immuno-Oncology Market Size & Forecast
1.6 Global Immuno-Oncology Market Size and Forecast by Region
1.6.1 Global Immuno-Oncology Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Immuno-Oncology Market Size by Region, (2019-2030)
1.6.3 North America Immuno-Oncology Market Size and Prospect (2019-2030)
1.6.4 Europe Immuno-Oncology Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Immuno-Oncology Market Size and Prospect (2019-2030)
1.6.6 South America Immuno-Oncology Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Immuno-Oncology Market Size and Prospect (2019-2030)
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Immuno-Oncology Product and Solutions
2.1.4 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.2 Merck & Co., Inc.
2.2.1 Merck & Co., Inc. Details
2.2.2 Merck & Co., Inc. Major Business
2.2.3 Merck & Co., Inc. Immuno-Oncology Product and Solutions
2.2.4 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck & Co., Inc. Recent Developments and Future Plans
2.3 Roche AG
2.3.1 Roche AG Details
2.3.2 Roche AG Major Business
2.3.3 Roche AG Immuno-Oncology Product and Solutions
2.3.4 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche AG Recent Developments and Future Plans
2.4 AstraZeneca, Plc
2.4.1 AstraZeneca, Plc Details
2.4.2 AstraZeneca, Plc Major Business
2.4.3 AstraZeneca, Plc Immuno-Oncology Product and Solutions
2.4.4 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 AstraZeneca, Plc Recent Developments and Future Plans
2.5 Sanofi S.A.
2.5.1 Sanofi S.A. Details
2.5.2 Sanofi S.A. Major Business
2.5.3 Sanofi S.A. Immuno-Oncology Product and Solutions
2.5.4 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi S.A. Recent Developments and Future Plans
2.6 Dendreon Pharmaceuticals
2.6.1 Dendreon Pharmaceuticals Details
2.6.2 Dendreon Pharmaceuticals Major Business
2.6.3 Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
2.6.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dendreon Pharmaceuticals Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Immuno-Oncology Product and Solutions
2.7.4 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Gilead Sciences Inc.
2.8.1 Gilead Sciences Inc. Details
2.8.2 Gilead Sciences Inc. Major Business
2.8.3 Gilead Sciences Inc. Immuno-Oncology Product and Solutions
2.8.4 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Gilead Sciences Inc. Recent Developments and Future Plans
2.9 Merck KGaA
2.9.1 Merck KGaA Details
2.9.2 Merck KGaA Major Business
2.9.3 Merck KGaA Immuno-Oncology Product and Solutions
2.9.4 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Merck KGaA Recent Developments and Future Plans
3.1 Global Immuno-Oncology Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Immuno-Oncology by Company Revenue
3.2.2 Top 3 Immuno-Oncology Players Market Share in 2023
3.2.3 Top 6 Immuno-Oncology Players Market Share in 2023
3.3 Immuno-Oncology Market: Overall Company Footprint Analysis
3.3.1 Immuno-Oncology Market: Region Footprint
3.3.2 Immuno-Oncology Market: Company Product Type Footprint
3.3.3 Immuno-Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Immuno-Oncology Consumption Value and Market Share by Type (2019-2024)
4.2 Global Immuno-Oncology Market Forecast by Type (2025-2030)
5.1 Global Immuno-Oncology Consumption Value Market Share by Application (2019-2024)
5.2 Global Immuno-Oncology Market Forecast by Application (2025-2030)
6.1 North America Immuno-Oncology Consumption Value by Type (2019-2030)
6.2 North America Immuno-Oncology Consumption Value by Application (2019-2030)
6.3 North America Immuno-Oncology Market Size by Country
6.3.1 North America Immuno-Oncology Consumption Value by Country (2019-2030)
6.3.2 United States Immuno-Oncology Market Size and Forecast (2019-2030)
6.3.3 Canada Immuno-Oncology Market Size and Forecast (2019-2030)
6.3.4 Mexico Immuno-Oncology Market Size and Forecast (2019-2030)
7.1 Europe Immuno-Oncology Consumption Value by Type (2019-2030)
7.2 Europe Immuno-Oncology Consumption Value by Application (2019-2030)
7.3 Europe Immuno-Oncology Market Size by Country
7.3.1 Europe Immuno-Oncology Consumption Value by Country (2019-2030)
7.3.2 Germany Immuno-Oncology Market Size and Forecast (2019-2030)
7.3.3 France Immuno-Oncology Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Immuno-Oncology Market Size and Forecast (2019-2030)
7.3.5 Russia Immuno-Oncology Market Size and Forecast (2019-2030)
7.3.6 Italy Immuno-Oncology Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Immuno-Oncology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Immuno-Oncology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Immuno-Oncology Market Size by Region
8.3.1 Asia-Pacific Immuno-Oncology Consumption Value by Region (2019-2030)
8.3.2 China Immuno-Oncology Market Size and Forecast (2019-2030)
8.3.3 Japan Immuno-Oncology Market Size and Forecast (2019-2030)
8.3.4 South Korea Immuno-Oncology Market Size and Forecast (2019-2030)
8.3.5 India Immuno-Oncology Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Immuno-Oncology Market Size and Forecast (2019-2030)
8.3.7 Australia Immuno-Oncology Market Size and Forecast (2019-2030)
9.1 South America Immuno-Oncology Consumption Value by Type (2019-2030)
9.2 South America Immuno-Oncology Consumption Value by Application (2019-2030)
9.3 South America Immuno-Oncology Market Size by Country
9.3.1 South America Immuno-Oncology Consumption Value by Country (2019-2030)
9.3.2 Brazil Immuno-Oncology Market Size and Forecast (2019-2030)
9.3.3 Argentina Immuno-Oncology Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Immuno-Oncology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Immuno-Oncology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Immuno-Oncology Market Size by Country
10.3.1 Middle East & Africa Immuno-Oncology Consumption Value by Country (2019-2030)
10.3.2 Turkey Immuno-Oncology Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Immuno-Oncology Market Size and Forecast (2019-2030)
10.3.4 UAE Immuno-Oncology Market Size and Forecast (2019-2030)
11.1 Immuno-Oncology Market Drivers
11.2 Immuno-Oncology Market Restraints
11.3 Immuno-Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Immuno-Oncology Industry Chain
12.2 Immuno-Oncology Upstream Analysis
12.3 Immuno-Oncology Midstream Analysis
12.4 Immuno-Oncology Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Immuno-Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Immuno-Oncology Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Immuno-Oncology Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Immuno-Oncology Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 6. Bristol-Myers Squibb Major Business
Table 7. Bristol-Myers Squibb Immuno-Oncology Product and Solutions
Table 8. Bristol-Myers Squibb Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Bristol-Myers Squibb Recent Developments and Future Plans
Table 10. Merck & Co., Inc. Company Information, Head Office, and Major Competitors
Table 11. Merck & Co., Inc. Major Business
Table 12. Merck & Co., Inc. Immuno-Oncology Product and Solutions
Table 13. Merck & Co., Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Merck & Co., Inc. Recent Developments and Future Plans
Table 15. Roche AG Company Information, Head Office, and Major Competitors
Table 16. Roche AG Major Business
Table 17. Roche AG Immuno-Oncology Product and Solutions
Table 18. Roche AG Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Roche AG Recent Developments and Future Plans
Table 20. AstraZeneca, Plc Company Information, Head Office, and Major Competitors
Table 21. AstraZeneca, Plc Major Business
Table 22. AstraZeneca, Plc Immuno-Oncology Product and Solutions
Table 23. AstraZeneca, Plc Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. AstraZeneca, Plc Recent Developments and Future Plans
Table 25. Sanofi S.A. Company Information, Head Office, and Major Competitors
Table 26. Sanofi S.A. Major Business
Table 27. Sanofi S.A. Immuno-Oncology Product and Solutions
Table 28. Sanofi S.A. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Sanofi S.A. Recent Developments and Future Plans
Table 30. Dendreon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Dendreon Pharmaceuticals Major Business
Table 32. Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
Table 33. Dendreon Pharmaceuticals Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Dendreon Pharmaceuticals Recent Developments and Future Plans
Table 35. Novartis Company Information, Head Office, and Major Competitors
Table 36. Novartis Major Business
Table 37. Novartis Immuno-Oncology Product and Solutions
Table 38. Novartis Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Novartis Recent Developments and Future Plans
Table 40. Gilead Sciences Inc. Company Information, Head Office, and Major Competitors
Table 41. Gilead Sciences Inc. Major Business
Table 42. Gilead Sciences Inc. Immuno-Oncology Product and Solutions
Table 43. Gilead Sciences Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Gilead Sciences Inc. Recent Developments and Future Plans
Table 45. Merck KGaA Company Information, Head Office, and Major Competitors
Table 46. Merck KGaA Major Business
Table 47. Merck KGaA Immuno-Oncology Product and Solutions
Table 48. Merck KGaA Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Merck KGaA Recent Developments and Future Plans
Table 50. Global Immuno-Oncology Revenue (USD Million) by Players (2019-2024)
Table 51. Global Immuno-Oncology Revenue Share by Players (2019-2024)
Table 52. Breakdown of Immuno-Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Immuno-Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Immuno-Oncology Players
Table 55. Immuno-Oncology Market: Company Product Type Footprint
Table 56. Immuno-Oncology Market: Company Product Application Footprint
Table 57. Immuno-Oncology New Market Entrants and Barriers to Market Entry
Table 58. Immuno-Oncology Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Immuno-Oncology Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Immuno-Oncology Consumption Value Share by Type (2019-2024)
Table 61. Global Immuno-Oncology Consumption Value Forecast by Type (2025-2030)
Table 62. Global Immuno-Oncology Consumption Value by Application (2019-2024)
Table 63. Global Immuno-Oncology Consumption Value Forecast by Application (2025-2030)
Table 64. North America Immuno-Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Immuno-Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Immuno-Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Immuno-Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Immuno-Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Immuno-Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Immuno-Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Immuno-Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Immuno-Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Immuno-Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Immuno-Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Immuno-Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Immuno-Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Immuno-Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Immuno-Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Immuno-Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Immuno-Oncology Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Immuno-Oncology Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Immuno-Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Immuno-Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Immuno-Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Immuno-Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Immuno-Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Immuno-Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Immuno-Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Immuno-Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Immuno-Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Immuno-Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Immuno-Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Immuno-Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Immuno-Oncology Raw Material
Table 95. Key Suppliers of Immuno-Oncology Raw Materials
List of Figures
Figure 1. Immuno-Oncology Picture
Figure 2. Global Immuno-Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Immuno-Oncology Consumption Value Market Share by Type in 2023
Figure 4. Immune Checkpoint Inhibitors
Figure 5. Cytokine-Based Immunotherapy
Figure 6. Cancer Vaccines
Figure 7. CAR-T Cell Therapy
Figure 8. Others
Figure 9. Global Immuno-Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Immuno-Oncology Consumption Value Market Share by Application in 2023
Figure 11. Hospitals Picture
Figure 12. Drugstores Picture
Figure 13. Others Picture
Figure 14. Global Immuno-Oncology Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Immuno-Oncology Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Immuno-Oncology Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Immuno-Oncology Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Immuno-Oncology Consumption Value Market Share by Region in 2023
Figure 19. North America Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Immuno-Oncology Revenue Share by Players in 2023
Figure 25. Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Immuno-Oncology Market Share in 2023
Figure 27. Global Top 6 Players Immuno-Oncology Market Share in 2023
Figure 28. Global Immuno-Oncology Consumption Value Share by Type (2019-2024)
Figure 29. Global Immuno-Oncology Market Share Forecast by Type (2025-2030)
Figure 30. Global Immuno-Oncology Consumption Value Share by Application (2019-2024)
Figure 31. Global Immuno-Oncology Market Share Forecast by Application (2025-2030)
Figure 32. North America Immuno-Oncology Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Immuno-Oncology Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Immuno-Oncology Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Immuno-Oncology Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Immuno-Oncology Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Immuno-Oncology Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 42. France Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Immuno-Oncology Consumption Value Market Share by Region (2019-2030)
Figure 49. China Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 52. India Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Immuno-Oncology Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Immuno-Oncology Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Immuno-Oncology Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Immuno-Oncology Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Immuno-Oncology Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Immuno-Oncology Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Immuno-Oncology Consumption Value (2019-2030) & (USD Million)
Figure 66. Immuno-Oncology Market Drivers
Figure 67. Immuno-Oncology Market Restraints
Figure 68. Immuno-Oncology Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Immuno-Oncology in 2023
Figure 71. Manufacturing Process Analysis of Immuno-Oncology
Figure 72. Immuno-Oncology Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Bristol-Myers Squibb Merck & Co., Inc. Roche AG AstraZeneca, Plc Sanofi S.A. Dendreon Pharmaceuticals Novartis Gilead Sciences Inc. Merck KGaA
18 Mar 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
